206 - Tracking and Containing Antimicrobial-Resistant Health Care-Associated Infections With Novel Sequencing Approaches

Saturday, October 14, 2023

8:00 AM – 9:00 AM US ET

Location: 153 ABC

All relevant financial disclosures have been mitigated.

Moderator(s)

Patricia (Trish) Simner, PhD, D(ABMM)

Clinical Microbiologist/Associate Professor
The Johns Hopkins University School of Medicine
Baltimore, MA, United States
MR

Marie-Claire Rowlinson

Wadsworth Center
Albany, NY, United States

Slides
PH

Patrick Harris, PhD, DTMH, MRCP, FRACP, FRCPA

Staff Specialist - Microbiology / Research Fellow
Pathology Queensland/University of Queensland
Brisbane, Queensland, Australia

Slides

Disclosure(s):

Patricia (Trish) Simner, PhD, D(ABMM): Affinity Biosensors: Grant/Research Support (Ongoing); BD Diagnostics: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Biomerieux: Advisor/Consultant (Ongoing); Entasis: Advisor/Consultant (Ongoing); GeneCapture: Advisor/Consultant (Ongoing); Merck: Advisor/Consultant (Ongoing); OpGen Diagnostics Inc: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Qiagen Sciences Inc: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Shionogi Inc: Advisor/Consultant (Ongoing)

Marie-Claire Rowlinson: No financial relationships to disclose

Patrick N A Harris, PhD, DTMH, MRCP, FRACP, FRCPA: Gilead Biosciences: Grant/Research Support (Ongoing); OpGen Inc: Advisor/Consultant (Ongoing), Honoraria (Ongoing); Pfizer, Inc.: Honoraria (Terminated, May 3, 2023); Sandoz: Advisor/Consultant (Ongoing), Honoraria (Ongoing)

CME Credits: Maximum of 1 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1 hours of MOC Credit
CNE Credits: Maximum of 1 hours of ANCC Credit
ACPE Credits: ACPE 1 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-23-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe emerging sequencing based approaches used to track and contain antimicrobial resistant pathogens in clinical and public health laboratories;
identify how clinical and public health laboratories can collaborate to address containment of antimicrobial resistance threats through novel approaches;
explain the potential economic benefit of routine whole genome sequencing to support hospital infection control and public health initiatives

Presentations:

8:00 AM – 8:30 AM US ET

Public Health Perspective
Speaker: Marie-Claire Rowlinson – Wadsworth Center
8:30 AM – 9:00 AM US ET

Clinical Laboratory Perspective
Speaker: Patrick N A Harris, PhD, DTMH, MRCP, FRACP, FRCPA – Pathology Queensland/University of Queensland